Gary McMaster has been appointed CSO of Fremont, Calif.-based GenoSpectra. He joins the company from Eli Lilly, where he was director of target discovery and systems biology research. Previously, he was senior director of molecular biology at Pfizer, and he spent 10 years at Novartis and Ciba-Geigy. He also held research management positions at the Max Planck Institute for Immunology and at Hoffman-La Roche Pharmaceuticals. McMaster received a PhD in developmental biology from the Swiss Institute for Experimental Cancer Research.
The Indiana Proteomics Consortium has appointed three new members to its board of directors: Peter Kissinger, William Hunt, and Jack Gill.
Kissinger currently serves as chairman and CEO of BioAnalytical Systems, and holds a faculty position in bioanalytical chemistry at Purdue University. In 1974 he founded BioAnalytical Systems, a manufacturer of instrumentation and developer of software for biomedical and chemical research. Kissinger joined the faculty at Purdue in 1975.
Hunt is chairman of Hunt Capital Partners, an Indianapolis-based venture capital firm. He also served as chairman and CEO of Arvin, a global manufacturer of automotive components, and most recently held the position of vice chairman and president of ArvinMeritor, a global supplier of integrated systems, modules, and components for light vehicle, commercial truck, and trailer manufacturers.
Gill, a member of the faculty of Harvard Medical School and president of the Gill Foundation of Texas, also serves as an advisor to the Center for the Integration of Medicine and Innovative Technologies, a partnership between Harvard, MIT, and Harvard’s teaching hospitals. Gill has held the position of executive vice president of Spectra Physics, and in 1981 founded Vanguard Ventures, a Silicon Valley high-tech venture capital firm.
Large Scale Biology Corporation, in addition to reorganizing its management structure into three distinct business units with their own cost structure, has also announced the following executive promotions: Steve Garger, vice president for biomanufacturing; Gregory Pogue, vice president for R&D; Earl White, vice president for R&D; Gary Wolfe, vice president for bioinformatics and genomics; and Gary Garrigues, senior counsel for contracts and SEC affairs.